Skip to main content
. 2011 Oct;18(10):1632–1643. doi: 10.1128/CVI.00411-10

Fig. 3.

Fig. 3.

Determination of RVFHbαP binding to LPS. RVFHbαP bound to LPS in a dose-dependent manner. No binding of nRVFHbαP to LPS was observed. SsALF24 peptide was used as a positive control for binding, which showed significant binding in a dose-dependent manner. Values represent the means ± SD of triplicate determinations performed on different days. Levels of significance (*, P < 0.05; **, P < 0.001; compared with the nRVFHbαP-treated group) were calculated by an ANOVA test followed by a post hoc Bonferroni analysis.